STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
STAT [Unofficial]
June 4, 2026
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
Discussion in the ATmosphere